Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,231,728
-
Share change
-
-555,099
-
Total reported value
-
$125,377,552
-
Put/Call ratio
-
89%
-
Price per share
-
$4.97
-
Number of holders
-
72
-
Value change
-
-$10,523,669
-
Number of buys
-
32
-
Number of sells
-
39
Institutional Holders of HARPOON THERAPEUTICS INC - COM (HARP) as of Q1 2022
As of 31 Mar 2022,
HARPOON THERAPEUTICS INC - COM (HARP) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,231,728 shares.
The largest 10 holders included
BIOIMPACT CAPITAL LLC, New Leaf Venture Partners, L.L.C., MPM ASSET MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Artal Group S.A., and Candriam Luxembourg S.C.A..
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.